Occupational Skin Disease

Dermatologist and family practitioner practice patterns for occupational contact dermatitis.

Holness DL, Tabassum S, Tarlo SM, Liss GM, Silverman F, Manno M. Australas J Dermatol. 2007 Feb;48(1):22-7. Medical practitioners have a role in the recognition of occupational contact dermatitis. The longer the duration of symptoms before diagnosis, the poorer the outcome. Our objective was to understand...

Cross-reactions to desoximetasone and mometasone furoate in a patient with multiple topical corticosteroid allergies.

Donovan JC, Dekoven JG. Dermatitis. 2006 Sep;17(3):147-51. ABSTRACT: A 60-year-old man developed a bullous contact dermatitis after topical corticosteroid treatment of dermatitis on his lower leg. Subsequent patch testing showed cross-reactions to numerous group B and group D corticosteroids as well...

Workplace sensitizers - exploration of skin and lung routes of exposure, responses and prevention practices: preliminary studies

We held a 2-day workshop which brought together 58 researchers with experience in the host and environmental components of WRCD and OAA. In particular, we targeted those who have considered the two organ systems together (either from a mechanistic or response perspective). The goal was to co-develop a set of questions that need to be addressed in future work, and develop new collaborations to pursue these questions.

A systematic review of contact dermatitis treatment and prevention.

Saary J, Qureshi R, Palda V, DeKoven J, Pratt M, Skotnicki-Grant S, Holness L. J Am Acad Dermatol. 2005 Nov;53(5):845. BACKGROUND: Contact dermatitis (CD) is a common occupational disease. There have been no systematic reviews of CD treatment or prevention. METHODS: Multiple databases were...

Workplace prevention activities experienced by workers with contact dermatitis

We conducted a needs assessment pilot study to identify some common characteristics of workplaces in which workers develop CD. A survey was developed by the clinic team at the Occupational Disease Specialty Program at St. Michael’s Hospital (Toronto), and administered to 17 patients/workers who: (1) had a positive diagnosis of CD, and (2) were employed but stopped work because of complications related to their skin disease. People without a single identifiable workplace but who worked at multiple sites were not included in the study, in order to localize causes to a specific workplace.

Barriers to return-to-work for workers with contact dermatitis

Our goal was to identify possible barriers and facilitators to RTW for workers with WRCD. We surveyed 15 patients who were being assessed for possible work-related contact dermatitis at the St. Michael’s Hospital Occupational Health Clinic (Toronto). Our survey probed current work and disease status, and asked participants to identify factors that they perceived to be barriers and facilitators to the RTW process.

Physician-diagnosed asthma, respiratory and cutaneous symptoms, immunologic sensitization and exposures among cleaners

The objective of the study was to assess the prevalence of lung and skin symptoms and determine associations between exposures and symptoms. Questionnaires were completed by indoor cleaners and other building workers and results compared between the two groups.

Patch testing for auto mechanics

The objectives of the study were the compare the clinical features and patch test results of auto mechanics and machinists and propose additional allergens to be included on a mechanics tray. A retrospective chart review was conducted of all mechanics and machinists evaluated between 2002 and 2005 in the OHC at SMH. Clinical information and patch test results were abstracted.

Quality of life in patients with latex allergy.

Al-Otaibi S, Tarlo SM, House R. Occup Med (Lond). 2005 Mar;55(2):88-92. Epub 2005 Feb 8. BACKGROUND: Exposure to natural rubber latex (NRL) may lead to a variety of allergic clinical manifestations that may affect the quality of life (QOL). AIM: To assess QOL of patients with different...

Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990-2001.

Bernstein DI, Wanner M, Borish L, Liss GM; Immunotherapy Committee, American Academy of Allergy, Asthma and Immunology. J Allergy Clin Immunol. 2004 Jun;113(6):1129-36. BACKGROUND: Fatal reactions associated with skin testing and injection immunotherapy have not been surveyed in North America since...